
Uncover the next big thing with 33 elite penny stocks that balance risk and reward.
To own Envista, you need to believe its dental portfolio can translate modest revenue growth into healthier earnings while managing regulatory and cost pressures. The Suzhou expansion and 2025 product launches may support margins and emerging markets growth, but they do not fundamentally change the near term risk from China’s Volume Based Procurement reforms or tariff volatility, which still loom large over pricing and profitability.
The most relevant recent development alongside the Suzhou news is Envista’s confirmation of 2026 core sales growth guidance at 2% to 4%. That forecast frames how much the new facility and fresh consumables, like OptiBond 360 and SimpliCore Composite, might help the company offset pressures in brackets, wires, and implants, and whether its emerging markets push can meaningfully support earnings in the next couple of years.
But despite this progress, investors should still pay close attention to the risk that China’s pricing reforms could...
Read the full narrative on Envista Holdings (it's free!)
Envista Holdings' narrative projects $3.1 billion revenue and $95.2 million earnings by 2029. This requires 3.9% yearly revenue growth and roughly a $48 million earnings increase from $47.0 million today.
Uncover how Envista Holdings' forecasts yield a $28.67 fair value, a 11% upside to its current price.
Some of the most optimistic analysts already expected revenue near US$2.9 billion and earnings of about US$212.7 million by 2028, so you should weigh how the Suzhou expansion interacts with their view that local manufacturing can structurally lower costs in emerging markets and decide whether that more bullish path still feels realistic after this latest news.
Explore 3 other fair value estimates on Envista Holdings - why the stock might be worth just $28.67!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Our daily scans reveal stocks with breakout potential. Don't miss this chance:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com